Insiders Mayne Pharma Group Limited

Equities

MYX

AU000000MYX0

Market Closed - Australian S.E. Other stock markets 02:10:14 2024-05-09 EDT			5-day change	1st Jan Change
7.12 ^AUD	-0.28%		+4.71%	+15.77%

02-26	Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15%	MT
02-25	Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mayne Pharma Group Limited Approves Election of Anne Lockwood	11-29	CI
Mayne Pharma Gets Go-Ahead for Resignation of EY as Auditor	11-03	MT
Mayne Pharma Group Limited Announces Retirement of Carolyn Myers from the Board At the End of July 2023	23-07-26	CI
Services Data and Factory Orders Anticipation Drag Exchange-Traded Funds, Stock Futures Lower	22-12-05	MT
Mayne Pharma Group Limited Announces Executive Changes Effective from 1 October 2022	22-09-27	CI
Mayne Pharma Group Limited Appoints Mr. Shawn Patrick O'brien as Chief Executive Officer	22-09-27	CI
Mayne Pharma Group Limited Announces Management Changes	22-08-30	CI
Mayne Pharma Group CEO to Retire	22-08-19	MT
Scott Richards Plans to Retire as CEO of Mayne Pharma Group Limited	22-08-18	CI
Mayne Pharma Names New CFO; Shares Jump 5%	22-07-21	MT
Ann Custin Accepts to Join the Board and Audit and Risk Committee of Mayne Pharma Group Limited	22-03-21	CI
Mayne Pharma Group Limited Announces Management Changes	22-01-16	CI
Mayne Pharma Group Limited Appoints Carolyn Myers to the Board	21-10-03	CI
Mayne Pharma Group Limited Announces Board Changes	21-08-26	CI
Mayne Pharma Group Limited Appoints Peter Paltoglou as Chief Financial Officer	20-09-28	CI
Mayne Pharma : Toni Nesci named head of Mayne Contract Services and New Website Launched	20-06-03	AQ
Mayne Pharma Group Limited Announces Executive Changes	20-03-19	CI
Mayne Pharma Group Limited Announces the Cessation of Ron Best as Director Effective from 22 November 2019	19-11-24	CI
Mayne Pharma Group Limited Announces Retirement of Ron Best as Non-Executive Director	19-10-20	CI
Mayne Pharma Group Limited Announces FDA Approves Trade Name Lexette(TM) (halobetasol propionate) Foam, 0.05%	19-04-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Mayne Pharma Group Limited

Equities

MYX

AU000000MYX0

Insiders

Filters